
|Articles|May 2, 2004
- Pharmaceutical Technology-05-02-2004
- Volume 28
- Issue 5
FDA Eyes Manufacturing Innovation to Boost Drug Development
Author(s)Jill Wechsler
New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.
Advertisement
Articles in this issue
over 22 years ago
In The Spotlight-May 2004over 22 years ago
Prepare for Bar Codingover 22 years ago
aaiPharma Situation Underscores The Need for Due Diligenceover 22 years ago
Excipient Functionalityover 22 years ago
May 2004Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
4
From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early
5




